The oil majors that operate Kazakhstan’s second-largest field, Kashagan, have filed for international arbitration of their dispute with the government over a $5 billion environmental fine , according to Shell Plc . The move complicates what was already a contentious relationship between the Kazakh authorities and the companies that run some of its biggest fields. Multiple arbitrations have been un...
The oil majors that operate Kazakhstan’s second-largest field, Kashagan, have filed for international arbitration of their dispute with the government over a $5 billion environmental fine , according to Shell Plc . The move complicates what was already a contentious relationship between the Kazakh authorities and the companies that run some of its biggest fields. Multiple arbitrations have been underway on different issues for several years, with tens of billions of dollars potentially at stake. Kazakhstan’s government recently told the companies that it’s taking a separate disagreement over two untapped oil deposits near Kashagan to arbitration, people familiar with the matter said. The country has been seeking the return of the fields, called Aktoty and Kairan, to state ownership for several years, amid a push to ensure all of its resources are fully developed . The companies’ decision to challenge the environmental fine comes after a court in Astana in December denied the Kashagan venture’s appeal against the penalty. “Despite disputing the allegations, and attempting to resolve these issues through dialogue, these efforts have not resulted in a solution,” a Shell spokesperson said. “Therefore, the international shareholders have concluded that they have no choice but to initiate a request for arbitration under international treaties.” Kazakhstan’s Ministry of Ecology and Natural Resources declined to comment. Kazakhstan is Central Asia’s largest oil producer and a key supplier to Europe. The nation’s importance has only increased as the continent moved away from Russian energy supplies following the 2022 invasion of Ukraine. The latest claims add to a wider $166 billion dispute between Kazakhstan and the oil majors over Kashagan. The country’s authorities have multiple claims in international arbitration related to lost revenue, cost recovery, environmental violations and deals that were allegedly tainted by corruption. Most recently, the oil majors that operate...
Olympic champion Keely Hodgkinson says she feels "closer than ever" to breaking the women's 800m outdoor record - the longest-standing world record in athletics.
Olympic champion Keely Hodgkinson says she feels "closer than ever" to breaking the women's 800m outdoor record - the longest-standing world record in athletics.
Itron ( ITRI ) on Monday said that it plans to offer $600 million in aggregate principal amount of convertible senior notes due 2032 in a private placement to qualified institutional buyers under Rule 144A of the Securities Act. The company said it intends to grant initial purchasers an option to buy up to an additional $90 million of the notes within a 13 day period from issuance. Itron expects t...
Itron ( ITRI ) on Monday said that it plans to offer $600 million in aggregate principal amount of convertible senior notes due 2032 in a private placement to qualified institutional buyers under Rule 144A of the Securities Act. The company said it intends to grant initial purchasers an option to buy up to an additional $90 million of the notes within a 13 day period from issuance. Itron expects to use part of the proceeds to fund capped call transactions aimed at reducing potential dilution from conversion of the notes. It also plans to use up to about $125 million to repurchase shares concurrently with the pricing of the offering. The remainder of the proceeds will be used to repay its 0.00% convertible senior notes due 2026 and for general corporate purposes. The notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption. ITRI +0.16% premarket to $99.7. Source: Press Release More on Itron Itron: Acquisitions Come At A Price Itron: Despite A Cheap Relative Valuation, Shares Don't Justify An Upgrade Now Itron: Staying Bullish On Q4 Beat And Strategic M&A Itron upgraded to Buy at Baird on grid modernization opportunity Itron outlines $2.35B-$2.45B 2026 revenue outlook as resiliency acquisitions drive new segment
Recent performance snapshot Baidu (NasdaqGS:BIDU) has seen mixed share performance lately, with a 1 day return of about a 1% decline and a roughly flat move over the past week, while the month return shows a 16% decline. Over longer periods, the stock reflects a 14% gain in the past 3 months, about 49% total return over the past year, and a modest 3 year total return of roughly 3%, compared with a...
Recent performance snapshot Baidu (NasdaqGS:BIDU) has seen mixed share performance lately, with a 1 day return of about a 1% decline and a roughly flat move over the past week, while the month return shows a 16% decline. Over longer periods, the stock reflects a 14% gain in the past 3 months, about 49% total return over the past year, and a modest 3 year total return of roughly 3%, compared with a 5 year total return of about a 52% decline. See our latest analysis for Baidu. Baidu’s recent 30...
In this article RAAQ Follow your favorite stocks CREATE FREE ACCOUNT European startup IQM is aiming to build powerful quantum computers to rival the likes of Google and IBM. IQM Finland-based quantum computing startup IQM announced plans Monday to become one of Europe's first publicly listed companies in the sector. IQM will merge with special purpose acquisition company (SPAC), Real Asset Acquisi...
In this article RAAQ Follow your favorite stocks CREATE FREE ACCOUNT European startup IQM is aiming to build powerful quantum computers to rival the likes of Google and IBM. IQM Finland-based quantum computing startup IQM announced plans Monday to become one of Europe's first publicly listed companies in the sector. IQM will merge with special purpose acquisition company (SPAC), Real Asset Acquisition Corp as part of the listing in New York. The deal, which gives IQM an initial equity valuation of $1.8 billion, is pending shareholders' approval and other regulatory conditions being met, the firm said in a Monday statement. The company is eyeing the transaction being completed around June this year, with the listing to happen shortly after that. It's also considering a dual listing on the Helsinki stock exchange. Founded in 2018, IQM raised $320 million in a Series B funding round in September , which valued the company at $1 billion. The round was led by Ten Eleven Ventures, a U.S. cybersecurity-focused investment firm, while Finnish venture capital firm Tesi also invested. IQM is building full-stack, open-architecture quantum systems that can be deployed on-premise or accessed via the cloud. The merger could provide over $300 million in funding for the company, in the form of private investment in public equity financing and cash held in RAAQ's trust account, assuming no redemptions (when investors in the SPAC withdraw their money from the transaction ahead of the listing). Commercial deployment Quantum computing promises to run calculations vastly quicker than classical computers can, solving more complex problems and processing larger volumes of data. Proponents of the technology say it could be used to facilitate breakthroughs in areas like medicine, science and finance. While the tech is not yet deployed in commercial environments and still has significant technical obstacles to overcome to become viable, some analysts are particularly bullish on the quantum se...
Marks Group Wealth Management Inc increased its position in Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 23.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,527 shares of the semiconductor company's stock after purchasing an additional 1,443 shares during the quarter. Marks Group Wealth Manag...
Marks Group Wealth Management Inc increased its position in Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 23.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,527 shares of the semiconductor company's stock after purchasing an additional 1,443 shares during the quarter. Marks Group Wealth Management Inc's holdings in Taiwan Semiconductor Manufacturing were worth $2,102,000 as of its most recent filing with the Securities and Exchange Commission. A number of other large investors have also added to or reduced their stakes in the company. Jennison Associates LLC boosted its position in Taiwan Semiconductor Manufacturing by 26.7% in the 2nd quarter. Jennison Associates LLC now owns 12,046,792 shares of the semiconductor company's stock valued at $2,728,478,000 after buying an additional 2,537,760 shares during the last quarter. Brown Advisory Inc. increased its position in shares of Taiwan Semiconductor Manufacturing by 43.2% during the second quarter. Brown Advisory Inc. now owns 6,650,983 shares of the semiconductor company's stock worth $1,506,389,000 after acquiring an additional 2,006,745 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Taiwan Semiconductor Manufacturing by 109.5% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,526,160 shares of the semiconductor company's stock worth $798,640,000 after acquiring an additional 1,842,951 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its stake in shares of Taiwan Semiconductor Manufacturing by 268.2% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 2,499,677 shares of the semiconductor company's stock worth $566,152,000 after acquiring an additional 1,820,852 shares in the last quarter. Finally, Alliancebernstein L.P....
Zimmer Biomet ( ZBH ) declares $0.24/share quarterly dividend , in line with previous. Forward yield 0.97% Payable April 30; for shareholders of record March 31; ex-div March 31. The company has now announced a dividend of $0.24 for seventeen consecutive quarters. See ZBH Dividend Scorecard, Yield Chart, & Dividend Growth. More on Zimmer Biomet Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings C...
Zimmer Biomet ( ZBH ) declares $0.24/share quarterly dividend , in line with previous. Forward yield 0.97% Payable April 30; for shareholders of record March 31; ex-div March 31. The company has now announced a dividend of $0.24 for seventeen consecutive quarters. See ZBH Dividend Scorecard, Yield Chart, & Dividend Growth. More on Zimmer Biomet Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript Zimmer Biomet Holdings, Inc. (ZBH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Zimmer Biomet: Execution Remains The Sticking Point Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle Zimmer Biomet beats top-line and bottom-line estimates; initiates FY26 outlook and new stock repurchase authorization
(RTTNews) - GeneDx Holdings Corp. (WGS), a healthcare company, on Monday reported net loss in the fourth quarter despite higher revenue compared with the previous year.
(RTTNews) - GeneDx Holdings Corp. (WGS), a healthcare company, on Monday reported net loss in the fourth quarter despite higher revenue compared with the previous year.
Axsome Therapeutics press release ( AXSM ): Q4 GAAP EPS of -$0.56 beats by $0.13 . Revenue of $195.99M (+65.0% Y/Y) beats by $2.73M . The increase was driven by strong growth of AUVELITY and SUNOSI, and contributions from the recent launch of SYMBRAVO. AUVELITY net product sales were $155.1 million for the fourth quarter 2025 SUNOSI net product revenue was $36.7 million for the fourth quarter 2025...
Axsome Therapeutics press release ( AXSM ): Q4 GAAP EPS of -$0.56 beats by $0.13 . Revenue of $195.99M (+65.0% Y/Y) beats by $2.73M . The increase was driven by strong growth of AUVELITY and SUNOSI, and contributions from the recent launch of SYMBRAVO. AUVELITY net product sales were $155.1 million for the fourth quarter 2025 SUNOSI net product revenue was $36.7 million for the fourth quarter 2025 SYMBRAVO net product sales were $4.1 million for the fourth quarter 2025 More on Axsome Therapeutics Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline Axsome Therapeutics, Inc. (AXSM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Axsome Therapeutics Q4 2025 Earnings Preview Axsome Therapeutics announces prelim Q4, FY revenue above estimates Seeking Alpha’s Quant Rating on Axsome Therapeutics
Valerii Evlakhov/iStock via Getty Images What’s in a name? That which we call a rose, by any other name, would smell as sweet. Romeo and Juliet, Act II, Scene II The Supreme Court finally released its ruling on President Trump’s use of the IEEPA (International Emergency Economic Powers Act of 1977) to impose universal tariffs on foreign goods, and the verdict was utterly unsurprising, at least to ...
Valerii Evlakhov/iStock via Getty Images What’s in a name? That which we call a rose, by any other name, would smell as sweet. Romeo and Juliet, Act II, Scene II The Supreme Court finally released its ruling on President Trump’s use of the IEEPA (International Emergency Economic Powers Act of 1977) to impose universal tariffs on foreign goods, and the verdict was utterly unsurprising, at least to those of us who have actually read the law. It was obvious the tariffs were not authorized by the law – the word tariff doesn’t appear in text – but it took the Supreme Court nearly a year to figure it out. That may not matter to the large companies that dominate business news, but it matters a lot to the companies that didn’t survive President Trump’s lawlessness. In case you missed it, the Court ruled that the President exceeded the authority granted to him by the IEEPA and that the tariffs were therefore not authorized. I’m not going to go over the legal aspects of the ruling because I’m not a lawyer and because the specifics are mostly irrelevant for the purposes of investing. If you’re interested in reading more, I’d suggest Gorsuch’s concurring opinion, which manages to skewer the conservative dissenters – Kavanaugh, Alito and Thomas – as well as the liberals who concurred, for their blatant hypocrisy. Neil will be sitting by himself in the Fed lunchroom. Here’s a link to the entire 170 pages of the opinion, with dissents. President Trump wasted no time in reimposing tariffs under Section 122 of the Trade Act of 1974, at 15% as of Saturday, on the whole world, apparently. Well, except for Canada and Mexico (although Canada is on shaky ground), a fairly lengthy list of product exemptions, some things covered by tariffs imposed under a different trade law, and maybe some countries that have already negotiated new trade deals. On the latter point, the new tariffs are in excess of what has been negotiated by some counterparties, most notably the EU : Trump’s imposition of...
Average EV selling prices dropped 3% year over year in December. Lower EV pricing is a “major theme” Cantor Fitzgerald analyst Andres Sheppard expects to continue this year. The silver lining in lower sales for Tesla is a higher market share.
Average EV selling prices dropped 3% year over year in December. Lower EV pricing is a “major theme” Cantor Fitzgerald analyst Andres Sheppard expects to continue this year. The silver lining in lower sales for Tesla is a higher market share.
Stepan press release ( SCL ): Q4 Non-GAAP EPS of -$0.02. Revenue of $553.89M (+5.4% Y/Y) misses by $16.71M . Global sales volume was down 3% year-over-year. Global sales volume, excluding the impact of the Philippines asset divestiture, was flat year-over-year. "As we look forward to 2026, we remain focused on delivering superior shareholder returns with a balanced approach between top line growth...
Stepan press release ( SCL ): Q4 Non-GAAP EPS of -$0.02. Revenue of $553.89M (+5.4% Y/Y) misses by $16.71M . Global sales volume was down 3% year-over-year. Global sales volume, excluding the impact of the Philippines asset divestiture, was flat year-over-year. "As we look forward to 2026, we remain focused on delivering superior shareholder returns with a balanced approach between top line growth and productivity cost out efforts. Today we announced Project Catalyst, which is a comprehensive plan designed to further optimize our asset base and create a more productive and agile organization to enable growth. Project Catalyst is expected to deliver approximately $100 million in pre-tax savings over the next two years. As part of Project Catalyst, Stepan will close its Fieldsboro, NJ site and decommission select assets at its Millsdale, IL and Stalybridge, UK facilities. Additionally, we are analyzing other opportunities to optimize our asset base, organization structure and operating model. We will announce future interventions once approved plans are in place," said Luis E. Rojo , President and Chief Executive Officer. "With these actions, we believe we are positioned to deliver full year Adjusted EBITDA growth and positive free cash flow in 2026, despite the ongoing market and tariff uncertainties." More on Stepan Seeking Alpha’s Quant Rating on Stepan Historical earnings data for Stepan Dividend scorecard for Stepan Financial information for Stepan
Former Philippine president Rodrigo Duterte was “pivotal” in the murder of thousands of people during his reign, prosecutors at the International Criminal Court (ICC) said on Monday, as they pushed for his trial to go ahead. The prosecutors at the Hague-based war crimes court have charged Duterte with three counts of murder as a crime against humanity, involving dozens of victims that accusers...
Former Philippine president Rodrigo Duterte was “pivotal” in the murder of thousands of people during his reign, prosecutors at the International Criminal Court (ICC) said on Monday, as they pushed for his trial to go ahead. The prosecutors at the Hague-based war crimes court have charged Duterte with three counts of murder as a crime against humanity, involving dozens of victims that accusers say were only a fraction of the real death toll in his clampdown on alleged drug users and...
Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Austin Carr considers the recurring cycles of large tech companies threatening to move out of California. Tech Across the Globe China AI is different: US markets are gripped by the “AI scare trade,” but in China the mood is far more upbeat. Instead of worrying about disru...
Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Austin Carr considers the recurring cycles of large tech companies threatening to move out of California. Tech Across the Globe China AI is different: US markets are gripped by the “AI scare trade,” but in China the mood is far more upbeat. Instead of worrying about disruption, investors are chasing perceived winners, drawn by AI’s growth prospects and its potential to drive cost savings for end users. Tech foreign policy: The Trump administration plans a new “Tech Corps” initiative to send thousands of US science and math graduates abroad to countries that host Peace Corps volunteers in an effort to boost international reliance on American technology and reduce global adoption of competing products from China. Xbox has a new boss: Microsoft AI executive Asha Sharma is taking over as leader of the Xbox and gaming business, succeeding longtime chief Phil Spencer, who is retiring. The company said it will recommit to support console users after years of developing products for mobile and PC players. Revalued OpenAI projects its revenue will jump to $280 billion in 2030 from more than $20 billion last year, signaling the view of executives that the startup has strong momentum in subscription sales for its AI software. At the same time, the company said it expects to spend an eye-watering $600 billion in 2030. Seeking greener pastures In a terse post on social media last week, Palantir made a surprise announcement : “We have moved our headquarters to Miami, Florida,” the data-analytics company said. It offered little context for the relocation. Still, it was immediately greeted as an endorsement of Florida’s tech ecosystem and low-tax environment, if not an implicit rejection of the “woke” backlash the firm has been facing elsewhere, including in its previous home of Denver , Colorado. “This is the tipping point!!!!” said former Miami mayor Fra...